Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine. - Wikidata - wikimedia - TriplyDB

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

http://www.wikidata.org/entity/Q34402129

about

Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma.Nanosecond Pulsed Electric Fields Enhance the Anti-tumour Effects of the mTOR Inhibitor Everolimus against Melanoma.Activation of Anti-tumor Immune Response by Ablation of HCC with Nanosecond Pulsed Electric Field.

P2860

Q26739959-6F93CD83-A1EF-465C-ADB2-A6809C49ADAB Q35684515-7457B54C-9D1E-4D73-B9FB-7FDC2C3FCF20 Q37561380-4F75086E-ADCB-4F5D-A3BD-A04E2E91D6CD Q52632449-5775D90F-AFE0-4A0D-88B3-C9F7988A8AC9

P2860

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

http://www.wikidata.org/entity/Q34402129

description

2014 nî lūn-bûn

@nan

2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@ast

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@en

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@nl

type

label

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@ast

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@en

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@nl

prefLabel

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@ast

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@en

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@nl

P1433

Q34402129-99EBEE33-38C0-416D-9D9C-91D49BF44B09

P1476

Q34402129-5F5A8EB6-D4FA-4EAB-AF09-321B4A81FA16

P2093

Q34402129-77CDC34E-1AB3-4D82-B7A3-E6B1150F1F24

Q34402129-8FA67A76-CF8C-4E3A-A4B5-23C9395864DF

Q34402129-B17BDBCA-CBA5-4AC1-BCB8-851EDB4D807A

Q34402129-C682F96A-E81A-4BBB-A98F-AF3EF7B4CE3C

Q34402129-DCA5BC82-7ED4-4C07-A76B-AD22AA469660

Q34402129-E6B3742A-C544-43DD-AD7C-17A6869F4723

P2860

Q34402129-02673E34-912A-4D57-BCCC-517FDFF1198E

Q34402129-0ADB16C9-E9F7-40D0-B695-1D450808B9EA

Q34402129-115C5331-15E4-42F0-A41E-4AE4CEF83F60

Q34402129-15262D20-C8D1-4384-B461-CE736A170CD7

Q34402129-187A9434-9D22-4CEA-87D4-4BD1264AC751

Q34402129-1F8E4B2F-BC04-4F09-895C-D5770CFE48B2

Q34402129-2B46FC11-356F-4AD3-B3FC-60224B2A1385

Q34402129-358A9BEA-BB5A-4B98-BB28-15623332F2A6

Q34402129-387F737F-195A-43A9-BA4F-F01B6820005A

Q34402129-40AD07D6-CCCA-4F93-90EC-6577D31A2311

P2888

Q34402129-732FB781-FBA9-43DF-9EBF-FA8C308435CF

P304

Q34402129-6390FAA6-E6FF-4FEB-8145-345D59B9278F

P31

Q34402129-F9206E8F-1E03-48C1-9B66-F455B0254AA6

P356

Q34402129-7C7F5836-9AA0-4C7A-BCA3-FFF8BAA61648

P433

Q34402129-CDE4D693-9635-49D9-B188-0588DE14B767

P478

Q34402129-6B52F5BD-DDA1-4FF1-80A6-9703BB058B83

P577

Q34402129-12EDAA62-7EB6-4C35-828D-7FB5B0C9C450

P5875

Q34402129-BA95582B-C25F-4EE4-AD07-8198655BB591

P6179

Q34402129-98568A75-2E29-4983-9A6B-33EC255B4111

P698

Q34402129-D283751D-3471-43C2-B68A-32186E92A9C9

P932

Q34402129-7AE5E36E-C3F6-42B0-B039-5FA4BCAAF894

P356

S12935-014-0098-4

P1433

Cancer Cell International

P1476

Enhanced breast cancer therapy with nsPEFs and low concentrations of gemcitabine.

@en

P2093

Jing Fang

http://www.w3.org/2001/XMLSchema#string

Jinsong Guo

http://www.w3.org/2001/XMLSchema#string

Jue Zhang

http://www.w3.org/2001/XMLSchema#string

Shan Wu

http://www.w3.org/2001/XMLSchema#string

Stephen J Beebe

http://www.w3.org/2001/XMLSchema#string

Wendong Wei

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Mechanisms of caspase activation and inhibition during apoptosis.

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes

Breast cancer tumor growth estimated through mammography screening data

The role of apoptosis in 2',2'-difluoro-2'-deoxycytidine (gemcitabine)-mediated radiosensitization.

Gemcitabine plus cisplatin for the treatment of metastatic breast cancer.

Necroptosis: an emerging form of programmed cell death.

Nanosecond, high-intensity pulsed electric fields induce apoptosis in human cells.

AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.

Genetically engineered mouse models of PI3K signaling in breast cancer.

P2888

s12935-014-0098-4

P304

98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12935-014-0098-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267931012

http://www.w3.org/2001/XMLSchema#string

P6179

1024129432

http://www.w3.org/2001/XMLSchema#string

P698

25379013

http://www.w3.org/2001/XMLSchema#string

P932

4209047

http://www.w3.org/2001/XMLSchema#string